For example, cyanidin-3-O-glucoside has been shown to reduce oxidative stress, inhibit NLRP3 activation, and alleviate steatosis in HFD-induced models by upregulating PINK1–Parkin expression and enhancing their mitochondrial localization, thereby promoting PINK1-mediated mitophagy. The gene discussed is NLRP3; the disease is steatosis.